ALB and diabetic kidney disease: Meanwhile, the urine albumin/creatinine ratio was remarkably reduced in diabetes patients who were treated with RES (500 mg/day) for 90 days, suggesting that RES may be protective against DKD by reducing urinary albumin excretion [13].